LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Search

West Pharmaceutical Services Inc

Closed

SectorHealthcare

260.87 -2.16

Overview

Share price change

24h

Current

Min

260.65

Max

262.97

Key metrics

By Trading Economics

Income

8.2M

140M

Sales

38M

804M

P/E

Sector Avg

40.81

105.69

EPS

1.96

Dividend yield

0.31

Profit margin

17.406

Employees

10,600

EBITDA

17M

215M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+33.01% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.31%

2.37%

Next Dividend date

19 Nov 2025

Market Stats

By TradingEconomics

Market Cap

51M

20B

Previous open

263.03

Previous close

260.87

News Sentiment

By Acuity

50%

50%

185 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

West Pharmaceutical Services Inc Chart

Past performance is not a reliable indicator of future results.

Related News

14 Nov 2025, 17:45 UTC

Earnings
Major Market Movers

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

14 Nov 2025, 17:31 UTC

Earnings
Major Market Movers

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

14 Nov 2025, 16:15 UTC

Major Market Movers

Scholar Rock Shares Rise on Renewed Apitegromab Hopes

14 Nov 2025, 23:56 UTC

Acquisitions, Mergers, Takeovers

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

14 Nov 2025, 23:02 UTC

Market Talk

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

14 Nov 2025, 22:35 UTC

Earnings
Acquisitions, Mergers, Takeovers

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

14 Nov 2025, 22:32 UTC

Acquisitions, Mergers, Takeovers

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

14 Nov 2025, 22:29 UTC

Earnings

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

14 Nov 2025, 22:00 UTC

Acquisitions, Mergers, Takeovers

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

14 Nov 2025, 21:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

14 Nov 2025, 21:18 UTC

Acquisitions, Mergers, Takeovers

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

14 Nov 2025, 20:27 UTC

Market Talk

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

14 Nov 2025, 20:23 UTC

Market Talk

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

14 Nov 2025, 20:17 UTC

Acquisitions, Mergers, Takeovers

Several State Attorneys General Oppose Railroad Merger -- WSJ

14 Nov 2025, 19:29 UTC

Market Talk
Earnings

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

14 Nov 2025, 18:44 UTC

Market Talk
Earnings

Disney's Growth Now Hinges More on ESPN -- Market Talk

14 Nov 2025, 18:27 UTC

Market Talk

Global Equities Roundup: Market Talk

14 Nov 2025, 18:27 UTC

Market Talk

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

14 Nov 2025, 18:20 UTC

Market Talk

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

14 Nov 2025, 17:20 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

14 Nov 2025, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Health Care Roundup: Market Talk

14 Nov 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

14 Nov 2025, 16:51 UTC

Market Talk

Starbucks Gets Holiday Sales Lift -- Market Talk

14 Nov 2025, 16:48 UTC

Market Talk

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

14 Nov 2025, 16:38 UTC

Market Talk

Unica Reports Higher Brazilian Sugar and Ethanol Production -- Market Talk

14 Nov 2025, 16:30 UTC

Acquisitions, Mergers, Takeovers

Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com

14 Nov 2025, 16:28 UTC

Market Talk

Ukraine Strike on Russian Port Lifts Distillates -- Market Talk

14 Nov 2025, 15:59 UTC

Market Talk

U.S. Natural Gas Inventories Rise More Than Expected -- Market Talk

14 Nov 2025, 15:06 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 Nov 2025, 15:06 UTC

Market Talk

Dollar Could Benefit From U.K., French Fiscal Concerns -- Market Talk

Peer Comparison

Price change

West Pharmaceutical Services Inc Forecast

Price Target

By TipRanks

33.01% upside

12 Months Forecast

Average 347.63 USD  33.01%

High 375 USD

Low 311 USD

Based on 10 Wall Street analysts offering 12 month price targets forWest Pharmaceutical Services Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

9

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

213.26 / 219.27Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

185 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat